Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Receptors, Androgen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05202301
What this trial is testing

A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely

Who this might be right for
Prostate Cancer
Bayer 13,779
Testing effectiveness (Phase 2)Study completedNCT00589472
What this trial is testing

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT02987829
What this trial is testing

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Who this might be right for
Metastatic Castrate-resistant Prostate CancerAdenocarcinoma, Prostate
Tracon Pharmaceuticals Inc. 72
Large-scale testing (Phase 3)Study completedNCT00539305
What this trial is testing

Hormone and Information Processing Study

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
University of Washington 22
Large-scale testing (Phase 3)Looking for participantsNCT07311694
What this trial is testing

A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 370
Testing effectiveness (Phase 2)Study completedNCT05670106
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 62
Testing effectiveness (Phase 2)Looking for participantsNCT07650240
What this trial is testing

Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial

Who this might be right for
Recurrent Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8Castration-Sensitive Prostate Cancer+9 more
Mayo Clinic 202
Testing effectiveness (Phase 2)Looking for participantsNCT05191680
What this trial is testing

TherApeutics in Early ProState Cancer (TAPS02)

Who this might be right for
Prostate Cancer
Cambridge University Hospitals NHS Foundation Trust 90
Large-scale testing (Phase 3)Looking for participantsNCT06520345
What this trial is testing

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 520
Testing effectiveness (Phase 2)Active Not RecruitingNCT05669664
What this trial is testing

Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers

Who this might be right for
Locally Advanced Salivary Gland CarcinomaMetastatic Salivary Gland CarcinomaRecurrent Salivary Gland Carcinoma+1 more
National Cancer Institute (NCI) 21
Early research (Phase 1)Looking for participantsNCT07140900
What this trial is testing

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Amgen 60
Not applicableWithdrawnNCT01275651
What this trial is testing

Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology
Large-scale testing (Phase 3)Looking for participantsNCT07723248
What this trial is testing

Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
ORIC Pharmaceuticals 600
Not applicableStudy completedNCT01516866
What this trial is testing

Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 58
Early research (Phase 1)Study completedNCT01696604
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects

Who this might be right for
Cachexia
GlaxoSmithKline 17
Large-scale testing (Phase 3)Ended earlyNCT04869943
What this trial is testing

Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Veru Inc. 52
Testing effectiveness (Phase 2)Study completedNCT00140478
What this trial is testing

Mifepristone (RU-486) in Androgen Independent Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma of Prostate
Dana-Farber Cancer Institute 48
Not applicableWithdrawnNCT05062174
What this trial is testing

Breast Cancer BRCA1 Carriers: a Pilot Study

Who this might be right for
BRCA1 MutationHigh-grade Serous Ovarian CancerTNBC - Triple-Negative Breast Cancer
Indiana University
Large-scale testing (Phase 3)Ended earlyNCT02438007
What this trial is testing

Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC

Who this might be right for
Prostate Cancer
LTN PHARMACEUTICALS, INC. 953
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07795177
What this trial is testing

A Prospective Study Based on Spatial Multi-omics to Predict the Efficacy of ADT Combined With Second-generation Novel Hormonal Agents in Metastatic Hormone-sensitive Prostate Cancer.

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer
Anhui Medical University 40
Next Page